1. Home
  2. VTRS vs PR Comparison

VTRS vs PR Comparison

Compare VTRS & PR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • PR
  • Stock Information
  • Founded
  • VTRS 1961
  • PR 2015
  • Country
  • VTRS United States
  • PR United States
  • Employees
  • VTRS N/A
  • PR N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • PR Oil & Gas Production
  • Sector
  • VTRS Health Care
  • PR Energy
  • Exchange
  • VTRS Nasdaq
  • PR Nasdaq
  • Market Cap
  • VTRS 11.0B
  • PR 8.8B
  • IPO Year
  • VTRS N/A
  • PR 2016
  • Fundamental
  • Price
  • VTRS $8.98
  • PR $12.95
  • Analyst Decision
  • VTRS Hold
  • PR Strong Buy
  • Analyst Count
  • VTRS 4
  • PR 17
  • Target Price
  • VTRS $10.50
  • PR $19.38
  • AVG Volume (30 Days)
  • VTRS 15.7M
  • PR 10.8M
  • Earning Date
  • VTRS 02-27-2025
  • PR 05-06-2025
  • Dividend Yield
  • VTRS 5.35%
  • PR 5.49%
  • EPS Growth
  • VTRS N/A
  • PR 16.80
  • EPS
  • VTRS N/A
  • PR 1.45
  • Revenue
  • VTRS $14,739,300,000.00
  • PR $5,000,734,000.00
  • Revenue This Year
  • VTRS N/A
  • PR $11.40
  • Revenue Next Year
  • VTRS $0.99
  • PR $3.30
  • P/E Ratio
  • VTRS N/A
  • PR $8.94
  • Revenue Growth
  • VTRS N/A
  • PR 60.23
  • 52 Week Low
  • VTRS $8.77
  • PR $11.84
  • 52 Week High
  • VTRS $13.55
  • PR $18.28
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 25.27
  • PR 41.37
  • Support Level
  • VTRS $9.25
  • PR $12.19
  • Resistance Level
  • VTRS $9.74
  • PR $13.47
  • Average True Range (ATR)
  • VTRS 0.38
  • PR 0.60
  • MACD
  • VTRS -0.07
  • PR -0.01
  • Stochastic Oscillator
  • VTRS 7.61
  • PR 39.36

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

Share on Social Networks: